COVID-19 and anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis: Are we facing an increase in the prevalence of autoimmune encephalitis?

Zandifar, Atefeh; Badrfam, Rahim

Zandifar, Atefeh; Badrfam, Rahim.

Zandifar A; Cardiovascular Research Center, Shahid Rajaei Educational & Medical Center, Alborz University of Medical Sciences, Karaj, Iran.
Badrfam R; Social Determinants of Health Research Center, Alborz University of Medical Sciences, Karaj, Iran.

J Med Virol ; 93(4): 1913-1914, 2021 04.

Article in English | MEDLINE | ID: covidwho-986278

Subject(s)

Anti-N-Methyl-D-Aspartate Receptor Encephalitis/etiology; COVID-19/complications; Anti-N-Methyl-D-Aspartate Receptor Encephalitis/epidemiology; Humans; Infant; Middle Aged; Prevalence; United Kingdom/epidemiology; Young Adult

Keywords

COVID-19; anti-N-methyl-d-aspartate receptor (anti-NMDAR); autoimmune encephalitis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Anti-N-Methyl-D-Aspartate Receptor Encephalitis / COVID-19 Type of study: Case report / Observational study Topics: Long Covid Limits: Adult / Humans / Infant / Middle aged / Young adult Country/Region as subject: Europa Language: English Journal: J Med Virol Year: 2021 Document Type: Article Affiliation country: Jmv.26745

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google